Telix Pharmaceuticals Ltd

TLX chart

Telix Pharmaceuticals Ltd news

• Telix Pharmaceuticals Limited (TLX) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Oct 27, 11:04 AM EDT

• Telix Pharmaceuticals (ASX:TLX): What Do Q3 Revenue Growth and New Imaging Milestones Mean for 2026?

  Kalkine · Oct 27, 7:33 AM EDT

• Telix Pharmaceuticals Limited (TLX) stock price, news, quote and history

  Yahoo Finance UK · Oct 27, 12:18 AM EDT

• Telix Pharmaceuticals Director Dr Christian Behrenbruch Acquires 38,750 Shares at $12.8935 Each

  Kalkine · Oct 26, 7:15 PM EDT

• CitiFirst MINIs Stop Loss Triggered for Telix Pharmaceuticals and Tuas Ltd Series

  Kalkine · Oct 26, 7:15 PM EDT

• Regis Healthcare And 2 Australian Insider Backed Growth Stocks

  Yahoo Finance · Oct 26, 4:11 PM EDT

• CitiFirst MINIs Suspended After Stop Loss Trigger Events on Telix Pharmaceuticals and Tuas Ltd

  Kalkine · Oct 26, 1:42 AM EDT

• Telix Pharmaceuticals (ASX:TLX): 3QFY26 Revenue, Imaging Approvals and Clinical Developments

  Kalkine · Oct 26, 12:57 AM EDT

• Buy, hold, sell: Telix Pharmaceuticals, BHP, CBA shares

  The Motley Fool Australia · Oct 25, 10:08 PM EDT

• Our Pick Of The Best Australian Growth Stocks In October 2026

  Yahoo Finance · Oct 25, 9:06 AM EDT

• Telix Pharmaceuticals: The ITM Deal Could Strengthen The Long-Term Buy Case (NASDAQ:TLX)

  Seeking Alpha · Oct 23, 4:13 AM EDT

• Telix Pharmaceuticals' (TLX) Outperform Rating Reiterated at Wedbush

  MarketBeat · Oct 23, 3:00 AM EDT

Telix Pharmaceuticals Ltd key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-K6-K2026-10-21
• 6-K6-K2026-09-30
• 6-K6-K2026-09-21
• 6-K6-K2026-09-14
• 6-K6-K2026-09-02
• 6-K6-K2026-09-01
• 6-K6-K2026-08-20
• 6-K6-K2026-07-21
• 6-K6-K2026-07-02
• 6-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS2026-05-21
• 6-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS2026-04-23
• 6-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS2026-04-21

About Telix Pharmaceuticals Ltd

Ticker

TLX (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

North Melbourne, Australia

Incorporated in

Australia

Fiscal year end

December 31

SEC CIK

2007191

Frequently asked questions